Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11707440 Esketamine for the treatment of depression

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Current Assignee
Janssen Pharmaceuticals
Janssen Pharmaceuticals
0
Date Filed
December 18, 2018
0
Date of Patent
July 25, 2023
0
Patent Applicant
Janssen Pharmaceuticals
Janssen Pharmaceuticals
0
Patent Application Number
16956403
0
Patent Citations
‌
US Patent 8710070 Opioid-ketamine and norketamine codrug combinations for pain management
0
‌
US Patent 8785500 Intranasal administration of ketamine to treat depression
0
‌
US Patent 9073819 Compositions, methods of use, and methods of treatment
0
‌
US Patent 9592207 Intranasal administration of ketamine to treat depression
0
‌
US Patent 9650352 Use of (2R, 6R)-hydroxynorketamine, (S)-dehydronorketamine and other stereoisomeric dehydro and hydroxylated metabolites of (R,S)-ketamine in the treatment of depression and neuropathic pain
0
‌
US Patent 10098854 Method for the treatment of depression
0
‌
US Patent 10307385 Gelling formulation containing ketamine
0
‌
US Patent 10335379 Oral dosage forms of ketamine
0
‌
US Patent 10406121 Application of R-ketamine and salt thereof as pharmaceuticals
0
‌
US Patent 10653629 Single layer oral dose of neuro-attenuating ketamine
0
•••
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
11707440
0
Patent Primary Examiner
‌
San Ming R Hui
0
CPC Code
‌
A61K 31/135
0
‌
A61K 9/0053
0
‌
A61P 25/24
0

Find more entities like US Patent 11707440 Esketamine for the treatment of depression

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.